Benzodiazepines in contemporary clinical practice

Professional Psychology: Research and Practice

Volumn 34, Issue 3, 2003, Pages 324-328

  Rivas Vazquez, Rafael A ^a  

^a MIAMI RESEARCH ASSOCIATES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0042879978     PISSN: 07357028     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7028.34.3.324     Document Type: Review

References (26)

1. Ayd, F. J. (2000). Lexicon of psychiatry, neurology and the neurosciences (2nd ed.). Philadelphia: Lippincott Williams & Wilkins.
2. Ballenger, J. C. (2000). Benzodiazepine receptor agonists and antagonists. In B. J. Sadock & V. A. Sadock (Eds.), Comprehensive textbook of psychiatry (7th ed., pp. 2317-2324). Philadelphia: Lippincott Williams & Wilkins.
3. Buffett-Jerrott, S. E., & Stewart, S. H. (2002). Cognitive and sedative effects of benzodiazepine use. Current Pharmaceutical Design, 8, 45-58.
4. Busto, U. E., Romack, M. K., & Sellers, E. M. (1996). Multiple drug use and psychiatric comorbidity in patients admitted to the hospital with severe benzodiazepine dependence. Journal of Clinical Psychopharmacology, 16, 51-57.
5. Ciraulo, D. A., & Sarid-Segal, O. (2000). Sedative-, hypnotic-, or anxiolytic-related abuse. In B. J. Sadock & V. A. Sadock (Eds.), Comprehensive textbook of psychiatry (7th ed., pp. 1071-1085). Philadelphia: Lippincott Williams & Wilkins.
6. Furukawa, T. A., Streiner, D. L., & Young, L. T. (2001). Is antidepressant-benzodiazepine combination therapy clinically more useful? A metaanalytic study, Journal of Affective Disorders, 65, 173-177.
7. Holbrook, A. M., Crowther, R., Lotter, A., Cheng, C., & King, D. (2000a). The diagnosis and management of insomnia in clinical practice: A practical evidence-based approach. Canadian Medical Association Journal, 162, 216-220.
8. Holbrook, A. M., Crowther, R., Lotter, A., Cheng, C., & King, D. (2000b). Meta-analysis of benzodiazepine use in the treatment of insomnia. Canadian Medical Association Journal, 162, 225-233.
9. Hyman, S. E., & Nestler, E. J. (1993). The molecular foundations of psychiatry. Washington, DC: American Psychiatric Press.
10. Kaplan, G. B., & Leite-Morris, K. A. (2002). Introduction to neuronal signaling pathways. In G. B. Kaplan & R. P. Hammer (Eds.), Brain circuitry and signaling in psychiatry: Basic science and clinical implications (pp. 31-66). Washington, DC: American Psychiatric Press.
11. Llorente, M. D., David, D., Golden, A. G., & Silverman, M. A. (2000). Defining patterns of benzodiazepine use in older adults. Journal of Geriatric Psychiatry and Neurology, 13, 150-160.
12. Mohler, H., Fritschy, J. M., & Rudolph, U. (2002). A new benzodiazepine pharmacology. Journal of Pharmacology and Experimental Therapeutics, 300, 2-8.
13. Morin, C. M. (2001). Combined treatments of insomnia. In M. T. Sammons & N. B. Schmidt (Eds.), Combined treatments for mental disorders: A guide to psychological and pharmacological interventions (pp. 111-130). Washington, DC: American Psychological Association.
14. Nutt, D. J., & Malizia, A. L. (2001). New insights into the role of the GABA(A)-benzodiazepine receptor in psychiatric disorder. British Journal of Psychiatry, 179, 390-396.
15. Otto, M. W., Pollack, M. H., Sachs, G. S., Reiter, S. R., Meltzer-Brody, S., & Rosenbaum, J. F. (1993). Discontinuation of benzodiazepine treatment: Efficacy of cognitive-behavioral therapy for patients with panic disorder. American Journal of Psychiatry, 150, 1485-1490.
16. Physician's desk reference. (2003). (57th ed.). Montvale, NJ: Medical Economics Data.
17. Rickels, K., & Rynn, M. (2002). Pharmacotherapy of generalized anxiety disorder. Journal of Clinical Psychiatry, 63(Suppl. 14), 9-16.
18. Rudolph, U., Crestani, F., Benke, D., Brunig, I., Benson, J. A., Fritschy, J. M., et al. (1999). Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature, 401, 796-800.
19. Sellers, E. M., Ciraulo, D. A., DuPont, R. L., Griffiths, R. R., Kosten, T. R., Romach, M. K., & Woody, G. E. (1993). Alprazolam and benzodiazepine dependence, Journal of Clinical Psychiatry, 54(Suppl), 64-75.
20. Sheehan, D. V. (2002). The management of panic disorder. Journal of Clinical Psychiatry, 63(Suppl. 14), 17-21.
21. Sieghart, W., & Sperk, G. (2002). Subunit composition, distribution and function of GABA(A) receptor subtypes. Current Topics in Medicinal Chemistry, 2, 795-816.
22. Smith, T. A. (2001). Type A gamma-aminobutyric acid (GABAA) receptor subunits and benzodiazepine binding: Significance to clinical syndromes and their treatment. British Journal of Biomedical Science, 58, 111-121.
23. Stafford, R. S., MacDonald, E. A., & Finkelstein, S. N. (2001). National patterns of medication treatment for depression: 1987 to 2001, Primary Care Companion to the Journal of Clinical Psychiatry, 3, 232-235.
24. Stahl, S. M. (2000). Essential pharmacology (2nd ed.). New York: Cambridge University Press.
25. Stahl, S. M. (2002). Don't ask, don't tell, but benzodiazepines are still the leading treatments for anxiety disorders. Journal of Clinical Psychiatry, 63, 756-757.
26. Walsh, J. K., & Schweizer, P. K. (1999). Ten-year trends in the pharmacological treatment of insomnia. Sleep, 22, 371-375.